Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70604 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Xinxin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Vitiligo, Lasers, Solid-State, Low-Level Light Therapy, Facial Dermatoses. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Background
Vitiligo is a common depigmenting disorder resulting from the loss of functional melanocytes. In certain refractory cases, conventional therapies fail to achieve complete repigmentation, leaving residual pigmented macules that can be cosmetically undesirable.
Aims
To assess the efficacy and safety of 532‐nm picosecond laser combined with hydroquinone cream for treating residual pigmentation in vitiligo. Patients We report two patients with stable generalized vitiligo who received 532‐nm picosecond laser treatment for residual pigmented macules. Patients subsequently applied 2% hydroquinone cream for 1–2 months. Clinical outcomes and adverse events were recorded. Written informed consent was obtained from both patients.
Results
Marked reduction in residual pigmentation was observed in both patients, with cosmetically favorable outcomes. Mild erythema and burning sensation occurred immediately after treatment and resolved within 1 week.
Conclusions
The 532‐nm picosecond laser, followed by topical hydroquinone, appears to be an effective and well‐tolerated approach for managing residual pigmentation in vitiligo. This reverse depigmentation strategy may serve as a valuable adjunct to enhance skin tone uniformity in selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking University People's Hospital, Beijing, China.
ORCID-Profile: Xuhai Yuan, Xiaolan Ding, Fang Wang
Förderung
- Beijing Municipal Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Li, X., Yuan, X., Du, J., Ding, X., & Wang, F. (2025). Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70604
Vancouver
Li X, Yuan X, Du J, Ding X, Wang F. Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70604
BibTeX
@article{Li2025,
author = {Li, Xinxin and Yuan, Xuhai and Du, Juan and Ding, Xiaolan and Wang, Fang},
title = {Depigmentation Therapy of Refractory Facial Vitiligo Using 532‐Nm Picosecond Laser: Two Case Reports and Literature Review},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70604}
}
EUVIMED